Clinical significance of hormonal receptor status of malignant ovarian tumors

Clinical significance of hormonal receptor status of malignant ovarian tumors

Objectives: To study hormonal receptor status (HRS) of malignant ovarian tumors (MOT) and determine its clinical significance. Patients and Methods: Retrospective analysis of case histories of 284 patients with MOT of different genesis of I–IV stages was carried out; immunohistochemical study of par...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Datum:	2014
Hauptverfasser:	Tkalia, I.G., Vorobyova, L.I., Svintsitsky, V.S., Nespryadko, S.V., Goncharuk, I.V., Lukyanova, N.Y., Chekhun, V.F.
Format:	Artikel
Sprache:	English
Veröffentlicht:	Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2014
Schriftenreihe:	Experimental Oncology
Schlagworte:	Original contributions
Online Zugang:	http://dspace.nbuv.gov.ua/handle/123456789/145343
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:	Clinical significance of hormonal receptor status of malignant ovarian tumors / I.G. Tkalia, L.I. Vorobyova, V.S. Svintsitsky, S.V. Nespryadko, I.V. Goncharuk, N.Y. Lukyanova, V.F. Chekhun // Experimental Oncology. — 2014. — Т. 36, № 2. — С. 125-133. — Бібліогр.: 39 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Ähnliche Einträge

Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
von: Tkalia, I.G., et al.
Veröffentlicht: (2014)

Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers
von: Buchynska, L.G., et al.
Veröffentlicht: (2009)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
von: Chekhun, S.V., et al.
Veröffentlicht: (2014)

The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats
von: Tkalia, I.G., et al.
Veröffentlicht: (2015)

Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
von: Zalutski, I.V., et al.
Veröffentlicht: (2017)

Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
von: Yalovenko, T.M., et al.
Veröffentlicht: (2016)

Recurrence of borderline ovarian tumors
von: Svintsitskiy, V.S., et al.
Veröffentlicht: (2013)

Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
von: Ryabtseva, O.D., et al.
Veröffentlicht: (2013)

Clinical significance of hormonal receptor status of malignant ovarian tumors
von: I. G. Tkalia, et al.
Veröffentlicht: (2014)

Quantitative analysis of SLC34A2 expression in different types of ovarian tumors
von: Shyian, M., et al.
Veröffentlicht: (2011)

Expression of steroid and peptide hormone receptors, metabolic enzymes and EMT-related genes in prostate tumors in relation to the presence of the TMPRSS2/ERG fusion
von: Gerashchenko, G.V., et al.
Veröffentlicht: (2018)

The study of phosphate transporter NaPi2b expression in different histological types of epithelial ovarian cancer
von: Gryshkova, V., et al.
Veröffentlicht: (2009)

Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2016)

Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
von: Lukyanova, N.Yu.
Veröffentlicht: (2010)

Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
von: Kryzhanivska, A.E., et al.
Veröffentlicht: (2018)

Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects
von: Berstein, L.M., et al.
Veröffentlicht: (2006)

Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

Survivin expression in ovarian cancer
von: Liguang, Z., et al.
Veröffentlicht: (2007)

Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristic
von: Pamuk, G.E., et al.
Veröffentlicht: (2006)

Comparison of various tissue and cell therapy approaches when restoring ovarian, hepatic and kidney’s function after chemotherapy-induced ovarian failure
von: Kozub, M.M., et al.
Veröffentlicht: (2017)

Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2016)

Expression of cathepsin l in nasopharyngeal carcinoma and its clinical significance
von: Xu, X., et al.
Veröffentlicht: (2009)

Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
von: Chekhun, V.F., et al.
Veröffentlicht: (2014)

Molecular profile and cell cycle in MCF-7 and MCF‑7/Dox cells exposed to conventional and liposomal forms of doxorubicin
von: Rusetskaya, N.V., et al.
Veröffentlicht: (2009)

Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
von: Bereznaya, N.M., et al.
Veröffentlicht: (2008)

Effects of alvocidib and carboplatin on ovarian cancer cells in vitro
von: Baumann, K.H., et al.
Veröffentlicht: (2013)

Efficacy of natural L-asparagine in the complex therapy for malignant tumors in experimental studies
von: Urazova, L.N., et al.
Veröffentlicht: (2011)

Patterns of hematological malignancies in chernobyl clean-up workers (1996–2005)
von: Gluzman, D., et al.
Veröffentlicht: (2006)

Nanohyperthermia of malignant tumors. II. In vivo tumor heating with manganese perovskite nanoparticles
von: Bubnovskaya, L., et al.
Veröffentlicht: (2012)

Effects of exogenous lactoferrin on phenotypic profile and invasiveness of human prostate cancer cells (DU145 and LNCaP) in vitro
von: Zadvornyi, T.V., et al.
Veröffentlicht: (2018)

CD150-mediated Akt signalling pathway in normal and malignant B cells
von: Yurchenko, M., et al.
Veröffentlicht: (2011)

Immunohistochemical studies of protein kinase D (PKD) 2 expression in malignant human lymph
von: Shlapatska, L.M., et al.
Veröffentlicht: (2006)

Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
von: Lukyanova, N.Yu., et al.
Veröffentlicht: (2009)

Prognostic significance of MDM2 gene expression in childhood neuroblastoma
von: Inomistova, M.V., et al.
Veröffentlicht: (2015)

Involvement of human beta-defensin-2 in regulation of malignant potential of cultured human melanoma cells
von: Gerashchenko, O., et al.
Veröffentlicht: (2014)

Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

Differential expression of CD150/SLAMF1 in normal and malignant b cells on the different stages of maturation
von: Gordiienko, I.M., et al.
Veröffentlicht: (2016)

Circadian rhythms of cytotoxic activity in peripheral blood mononuclear cells of patients with malignant melanoma
von: Gamaleia, N.F., et al.
Veröffentlicht: (2006)

Sensitization of human malignant lymphoid cells to etoposide by fucoidan, a brown seaweed polysaccharide
von: Philchenkov, A., et al.
Veröffentlicht: (2007)

Nanohyperthermia of malignant tumors.i. lanthanum-strontium manganite magnetic fluid as potential inducer of tumor hyperthermia
von: Solopan, S., et al.
Veröffentlicht: (2011)